Transjugular intrahepatic portosystemic shunts in patients with hereditary hemorrhagic telangiectasia: Failure to palliate gastrointestinal bleeding

Journal of Vascular and Interventional Radiology

Volumn 9, Issue 6, 1998, Pages 994-997

  Lee, Joon Y ^d   Korzenik, Joshua R ^a   DeMasi, Ronald ^d   Lih Brody, Lisa ^b   White Jr , Robert I ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

Gastrointestinal tract, hemorrhage; Shunts, portosystemic; Telangiectasia

Indexed keywords

AMINOCAPROIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DANAZOL; ESTROGEN; ETACRYNIC ACID; HYDROCHLOROTHIAZIDE; IRON; NICOTINE; NORADRENALIN; OCTREOTIDE; PROGESTERONE; RECOMBINANT ERYTHROPOIETIN; TESTOSTERONE; TRANEXAMIC ACID;

AGED; ARTICLE; ASCITES; BLOOD TRANSFUSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER BIOPSY; MALE; PARACENTESIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; STENT; SURGICAL APPROACH; TREATMENT OUTCOME;

EID: 0031771244     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(98)70439-7     Document Type: Article

References (22)

1. Martini GA. The liver in hereditary haemorrhagic telangiectasia: an inborn error of vascular structure with multiple manifestations: a reappraisal. Gut 1978; 19:531-537.
2. Porteous ME, Burn J, Proctor SJ. Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 1992; 29:527-530.
3. Plauchu H, de Chadarévian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32:291-297.
4. Ference BA, Shannon TM, White Jr RI, Aawin M, Burge CM. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest 1994; 106:1387-1390.
5. Roman G, Fisher M, Perl DP, Poser CM. Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osier-Weber disease): report of two cases and review of the literature. Ann Neurol 1978; 4:130-144.
6. Smith CR, Bartholomew LG, Cain JC. Hereditary hemorrhagic telangiectasia and gastrointestinal hemorrhage. Gastroenterology 1963; 44:1-6.
7. Cachin Y, Sauvage JP, Schwaab G. La maladie de Rendu-Osier: à propos de 50 cas suivis à l'Institut Gustave-Roussy. Ann Oto-Laryng (Paris) 1976; 93:103-108.
8. Driscoll JE, Rabe MA. Hemorrhagic telangiectasis of the gastrointestinal tract: an obscure source of gastrointestinal bleeding. Am Surg 1954; 20:1281-1290.
9. Rossini FP, Arrigoni A, Pennazia M. Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. Am J Gastroent 1993; 9:1424-1427.
10. Naveau S, Aubert A, Povnard T, Chaput JC. Long term results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation. Dig Dis Sci 1990; 35:821-826.
11. Mathus-Vliegen EMH. Laser treatment of intestinal vascular abnormalities. Int J Colorectal Dis 1989; 4:20-25.
12. Sargeant IR, Loizou LA, Rampton D, Tulloch M, Bown SG. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut 1993; 34:470-475.
13. Saba HI, Morelli GA, Logrono LA. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med 1994; 330:1789-1790.
14. Korzenik J, Topazian M, Burdge C, White R. Danazol in treatment of gastrointestinal hemorrhage secondary to hereditary hemorrhagic telangiectasia. Gastroenterology 1995; 108:A297.
15. Van Cutsem E, Rutgeerts P, Vantrappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 335: 953-955.
16. Harisson D. Use of estrogen in treatment of familial hemorrhagic telangiectasia. Laryngoscope 1982; 92:314-319.
17. Menefee M, Flessa H, Glueck H, Hogg S. Hereditary hemorrhagic telangiectasia: an electron microscopic study of the vascular lesions before and after therapy with hormones. Arch Otolaryngol 1975; 101:246-251.
18. Gelfand JA. Exploiting sex for therapeutic purposes. N Engl J Med 1983; 308:1417-1419.
19. Brohée D, Franken P, Fievez M, et al. High-output right ventricular failure secondary to hepatic arteriovenous microfistulae: selective arterial embolization treatment. Arch Intern Med 1984; 144:1282-1284.
20. Nikolopoulos N, Xynos E, Vassilakis JS. Familial occurrence of hyperdynamic circulation status due to intrahepatic fistulae in hereditary hemorrhagic telangiectasia. Hepato Gastroenterol 1988; 35:167-168.
21. Bourgeois N, Delcour C, Deviere J, et al. Osler-Weber-Rendu disease associated with hepatic involvement and high output heart failure. J Clin Gastroenterol 1990; 12:236-238.
22. Bernard G, Mion F, Henry L, Plauchu H, Paliard P. Hepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiological, and hemodynamic studies of 11 cases. Gastroenterology 1993; 105:482-487.